HDL and Atherosclerosis

Slides:



Advertisements
Similar presentations
The future of HDL raising
Advertisements

Lipids, Lipoproteins and Aging
Lipoprotein Structure, Function, and Metabolism
Lipoprotein Metabolism And Disorders
Lipoproteins Function: Transport of fat soluble substances
LIPOPROTEIN METABOLISM
Low Density Lipoprotein (LDL) LDL derived from VLDL as TAG in VLDL (and IDL) removed by lipoprotein lipase  LDL major cholesterol-carrying lipoprotein.
MCB 135K: Discussion.
Metabolism of HDL Dr Nikhat Siddiqi.
بسم الله الرحمن الرحيم.
Friend or Foe? High HDL Cholesterol. High Density Lipoprotein Origin: liver Content: 18-25% TC content 45-55% Protein 2-7% TG 20-30% Phospholipids Density:
Lipoprotein Structures, Function and Metabolism (1)
Lipoprotein Structure and Function
LIPOPROTEIN Mpenda F.N.
Aims 1.Outline the structural diversity of lipids. 2.Examine the biophysical characteristics of lipids. 3Outline the biochemical synthesis of fatty acids,
Plasma lipoproteins. Generalized structure of a plasma lipoprotein.
 The third major class of lipids  The three cyclohexane rings (A, B, C) are connected to a cyclopentane ring (D).  Significantly different structure.
1 LIPID TRANSPORT Lipoproteins Lipids are transported in the blood as lipoproteins are soluble in water because the surface consists of polar lipids.
Dr Abdul Lateef Assistant professor Dept of Biochemistry.
Lipoprotein Structures, Function and Metabolism (2)
ECDA September LIPID DIGESTION  Lipids in the diet are most commonly triglycerides or neutral fats found in both animals and plants. Cholesterols.
Lipoproteins The serum lipoproteins are complexes of lipids and specific proteins called "apoproteins". Functions of Lipoproteins Help to transport lipids.
بسم الله الرحمن الرحيم.
Low HDL remains a predictor of cardio- vascular risk in statin-treated patients Barter P et al., N Engl J Med 2007; 357:
1 Lipoproteins Seminar No A.1 - Lipids of Blood Plasma LipidPlasma concentration Cholesterol (C+CE)* Phospholipids Triacylglycerols Free fatty acids.
Lipoprotein Structure and Function LP core Triglycerides Cholesterol esters LP surface Phospholipids Proteins Cholesterol Are conjugated proteins, composed.
HANDBOOK OF DYSLIPIDEMIA AND ATHEROSCLEROSIS Part One Professor Jean-Charles Fruchart Department of Atherosclerosis (Inserm UR545) Pasteur Institute of.
Metabolism - Session 5, Lecture 1 Lipid metabolism and Transport Suggested reading: Marks’ Essentials of Medical Biochemistry, Chapter 30, Chapter 31,
Lipids in the diet are hydrolyzed in the small intestine, and the resultant fatty acids and monoglycerides are repackaged with apoB-48 into TG-enriched.
Lipoprotein Structure, Function, and Metabolism
Cholesterol metabolism
Lipoproteins and Atheroscloresis
Lipoproteins and Atheroscloresis
بسم الله الرحمن الرحيم.
Schematic overview of the role of LCAT in lipoprotein metabolism
LIPOPROTEINS A to Z.
Plasma Lipid Transport Role of HDL
Dr. Eman Shaat Professor of Medical Biochemistry and Molecular Biology
Biochemistry Lipoprotein and atherosclerosis Important.
LIPIDS AND LIPOPROTEINS Dr. Gamal Gabr
Paul Durrington  Atherosclerosis Supplements 
Apoprotein B, Small-Dense LDL and Impaired HDL Remodeling Is Associated With Larger Plaque Burden and More Noncalcified Plaque as Assessed by Coronary.
Lipoproteins Metabolism
Dyslipidemia in chronic kidney disease: Causes and consequences
Cholesterol and Lipoproteins
Figure 1 Overview of lipoprotein metabolism and effects of novel lipid-modulating approaches Figure 1 | Overview of lipoprotein metabolism and effects.
Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency  Don P. Wilson, MD, FNLA, Mark Friedman,
Nat. Rev. Cardiol. doi: /nrcardio
Effects of ethanol on lipids and atherosclerosis
Figure 4 Acute-phase HDL
Advanced Nutrition Lipids 5 MargiAnne Isaia, MD MPH.
Volume 7, Issue 5, Pages (May 2008)
HDL and Atherosclerosis
بسم الله الرحمن الرحيم.
Eveline Oestreicher Stock, MD, Christine T
Lipoproteins.
Copyright © 2016 Elsevier Inc. All rights reserved.
Scavenger Receptor B-1 Emerges as Anti-atherogenic Candidate
Daniel J. Rader, Ellen Puré  Cell Metabolism 
Volume 7, Issue 5, Pages (May 2008)
Figure 1 The major pathways of lipid metabolism
New insights into lipid metabolism in the nephrotic syndrome
Daniel J. Rader, Ellen Puré  Cell Metabolism 
Volume 76, Issue 4, Pages (August 2009)
Nat. Rev. Nephrol. doi: /nrneph
Lipoprotein Metabolism
Schematic representation of dyslipidaemia of metabolic syndrome.
Figure 2 Protective functions of HDL
Reverse cholesterol transport CETP is key in remodeling of HDL
Role of CETP in plasma cholesterol transport.
Presentation transcript:

HDL and Atherosclerosis

Atherosclerosis: A Progressive Process Préparation ESC Septembre 18/09/2018 Atherosclerosis: A Progressive Process Plaque Rupture/ Fissure & Thrombosis Occlusive Atherosclerotic Plaque Fatty Streak Fibrous Plaque Unstable Angina Normal MI Coronary Death Stroke Effort Angina Claudication Clinically Silent Critical Leg Ischemia Atherosclerosis is a progressive disease, typically starting in adolescence and developing over the course of several decades until clinically manifested as heat attack, stroke or peripheral vascular disease (intermittent claudication). Information on atherosclerosis is available at : http://en.wikipedia.org/wiki/Atherosclerosis. http://www.athero.org/ Increasing Age

Préparation ESC Septembre 18/09/2018 HDL Subpopulations Particle shape Apolipoprotein composition Discoidal Spherical A-I HDL A-I/A-II HDL E HDL Particle size Lipid-poor apoA-I HDL are the smallest and densest of the plasma lipoproteins. HDL exist in the plasma as a number of subpopulations of particles of varying shape, size, density and composition. The main apolipoproteins in HDL are apolipprotein (apo)A-I (70%) and apoA-II (20%). HDL also transport additional proteins such as CETP (cholesteryl ester transfer protein), LCAT (lecithin:cholesterol acyltransferase), PLTP (phospholipid transfer protein) and PON( paraoxonase). Most of the HDL particles in the plasma are spherical. Discoid HDL particles (nascent HDL) only exist transiently before conversion to spherical HDL particles. HDL particles carry cholesterol from the body's tissues to the liver for reprocessing or excretion. Reference Barter P, Rye K-A. High density cholesterol: the new target. A handbook for clinicians. Sherborne Gibbs, Birmingham, 2007 HDL2b HDL2a HDL3a HDL3b HDL3c

Préparation ESC Septembre 18/09/2018 Apolipoproteins Apo-A I carries ”good cholesterol” ( HDL ) Apo B carries ”bad cholesterol” ( LDL ) Apolipoproteins are components of both LDL and HDL cholesterol. The main apolipoproteins in HDL are apolipopotein A-I (apoA-I) and apolipoprotein A-II (apoA-II). These comprise about 70% and 20% of the total HDL protein, respectively. Most HDL particles also contain other minor apolipoproteins.

Préparation ESC Septembre 18/09/2018 HDL particles consist of a fatty core (mainly cholesteryl esters with a small amount of triglyceride), surrounded by a surface layer of phospholipids, unesterified cholesterol and apolipoproteins. Reference Barter P, Rye K-A. High density cholesterol: the new target. A handbook for clinicians. Sherborne Gibbs, Birmingham, 2005

Préparation ESC Septembre 18/09/2018 HDL Metabolism Bile A-I A-I FC LCAT CE CE FC FC CE ABCA1 SR-BI HL, EL Macrophage Liver CETP LDLR PLTP HDL metabolism is complex and presents a variety of targets for therapeutic intervention. These include: 1. HDL cholesteryl esters may be transferred to very-low-density lipoproteins (VLDL) and low-density lipoprotein (LDL) by CETP (cholesteryl ester transfer protein) and then removed from the plasma as components of these lipoproteins. 2. HDL cholestery esters (CE) may be selectively taken up by the liver in a process involving binding of HDL to SR-B1 (scavenger receptor type B1). 3. HDL, triglycerides and phospholipids are removed by hydrolysis catalysed by hepatic lipase (HL), endothelial lipase (EL), lipoprotein lipase (LPL) and possibly secretory phospholipase A2. 4. ApoA-I is independently metabolised following its dissociation from HDL during HDL remodelling. Reference Barter P, Rye K-A. High density cholesterol: the new target. A handbook for clinicians. Sherborne Gibbs, Birmingham, 2007. CE B TG Kidney VLDL/LDL

Metabolism of HDL Lipid-poor particles originate from the liver and intestine Plasma apolipoprotein A-I (apoA-I) acquires phospholipids and cholesterol from cell membranes, resulting in discoidal A-I HDL Esterification of cholesterol, resulting in formation of spherical HDL Remodelling of spherical HDL, leading to changes in composition and size

Préparation ESC Septembre 18/09/2018 Cycling of apoA-I between HDLs and a lipid-poor pool HDL CE TG Excretion through kidney CE Discoidal HDL CETP HL Lipid-poor apoA-I PLTP SRB1 HDL also transport proteins that are involved in HDL formation and remodelling. These include cholesteryl ester transfer protein (CETP), which remodels HDL into particles of varying size. Reference Barter P, Rye K-A. High density cholesterol: the new target. A handbook for clinicians. Sherborne Gibbs, Birmingham, 2007 CE TG CE TG CE CE UC CE LCAT

Préparation ESC Septembre 18/09/2018 Antiatherogenic Actions of HDL Reverse Cholesterol Transport Cellular Cholesterol Efflux Anti- inflammatory activity HDL Anti- apoptotic activity Anti- thrombotic activity Anti- oxidative activity Anti- infectious activity In addition to their role in reverse cholesterol transport, HDL have the ability to protect against atherosclerosis via a number of different mechanisms. HDL have been shown to inhibit oxidative modification of LDL (thereby reducing their atherogenicity) and inhibit expression of endothelial cell adhesion molecules. HDL also have anti-thrombotic effects, and stimulate nitric oxide generation, thereby reducing endothelial dysfunction. HDL are also implicated in the repair of damaged endothelium. Reference Barter P, Rye K-A. High density cholesterol: the new target. A handbook for clinicians. Sherborne Gibbs, Birmingham, 2005 Endothelial Repair Vasodilatory Activity Chapman et al. Curr Med. Res Opin. 2004,20:1253-1268 Assmann G. and Nofer JR, Annu Rev Med. 2003,53 : 321-41